# A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Study · id `cardio:ct-nct02227784` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02227784](<https://clinicaltrials.gov/study/NCT02227784>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02227784

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 366 participants.

## Technical summary

Registry record NCT02227784. Randomized; double masking; primary purpose treatment. Start 2014-10 (registry gives no type); primary completion 2015-12 (actual). Results posted on 2018-03-22.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 366 participants (enrolled count; ClinicalTrials.gov record NCT02227784, source copy `cardio:ctgov-nct02227784-2019-10-08`, retrieved 2026-10-31)
- Start date: 2014-10 (registry gives no type) (ClinicalTrials.gov record NCT02227784, source copy `cardio:ctgov-nct02227784-2019-10-08`, retrieved 2026-10-31)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02227784, source copy `cardio:ctgov-nct02227784-2019-10-08`, retrieved 2026-10-31)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02227784, source copy `cardio:ctgov-nct02227784-2019-10-08`, retrieved 2026-10-31)
- Results first posted: 2018-03-22 (ClinicalTrials.gov record NCT02227784, source copy `cardio:ctgov-nct02227784-2019-10-08`, retrieved 2026-10-31)
- Countries: United States; Puerto Rico (ClinicalTrials.gov record NCT02227784, source copy `cardio:ctgov-nct02227784-2019-10-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02227784-2019-10-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
- Acronym: ACCENTUATE
- Condition: Hyperlipidemia
- Intervention (Drug): Evacetrapib
- Intervention (Drug): Atorvastatin
- Intervention (Drug): Ezetimibe
- Intervention (Drug): Placebo
- Lead sponsor: Eli Lilly and Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention name matches this record: Ezetimibe (`cardio:ezetimibe`)
- Registry lists this organization as the lead sponsor: Eli Lilly and Company (`cardio:eli-lilly`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial (`cardio:pubmed-28412650`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 391f920180ed0e05fa7f246ea42fabb8ddebcb5bd0bf7844d8211b432c37fba5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
